<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04141683</url>
  </required_header>
  <id_info>
    <org_study_id>RESERVE</org_study_id>
    <nct_id>NCT04141683</nct_id>
  </id_info>
  <brief_title>Right VEntricular Contractile ReSERVE in Functional Tricuspid Regurgitation</brief_title>
  <acronym>RESERVE</acronym>
  <official_title>Prognostic Implication of Right Ventricular Contractile Reserve in Patients With Functional Tricuspid Regurgitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Leipzig</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the study is to investigate the prognostic value of right ventricular contractile
      reserve in patients with functional tricuspid regurgitation undergoing tricuspid valve repair
      or replacement.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Chronic volume overload in patients with severe tricuspid regurgitation (TR) leads to right
      ventricular (RV) dilatation, fibrosis and eventually failure. RV dysfunction is an important
      determinant of mortality in patients undergoing tricuspid valve surgery.

      Aim of the current study is to investigate the prognostic utility of right ventricular
      contractile reserve in patients with severe TR undergoing surgical or interventional
      tricuspid valve repair or tricuspid valve replacement.

      RV contractile reserve will be assessed using semi-supine bicycle stress echocardiography.

      Echocardiographic parameters are prone to altered loading conditions, such as volume
      overload. Load independent RV contractility can only be measured using invasive
      pressure-volume-loop (PVL) analysis. Therefore RV PVL analysis will be done using conductance
      catheter in a subset of patients who undergo right heart catheterization for clinical
      evaluation of pulmonary hypertension. Aim of this sub study is the validation of
      non-invasively derived RV contractile reserve with load independent markers of intrinsic RV
      contractility.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 10, 2019</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Death or heart failure hospitalization</measure>
    <time_frame>6-12 month</time_frame>
    <description>Death or heart failure hospitalization according to right ventricular contractile reserve.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Death</measure>
    <time_frame>6-12 month</time_frame>
    <description>Death according to right ventricular contractile reserve.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular Death</measure>
    <time_frame>6-12 month</time_frame>
    <description>Cardiovascular Death according to right ventricular contractile reserve.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Failure Hospitalization</measure>
    <time_frame>6-12 month</time_frame>
    <description>Heart Failure Hospitalization according to right ventricular contractile reserve.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intrinsic RV contractility</measure>
    <time_frame>Baseline</time_frame>
    <description>Correlation of RV contractile reserve with the slope of invasively derived right ventricular end systolic elastance.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">108</enrollment>
  <condition>Functional Tricuspid Regurgitation</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Stress Echocardiography</intervention_name>
    <description>Dynamic stress echocardiography using a cycle ergometer on a semi supine exercise table.</description>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Pressure volume loop analysis</intervention_name>
    <description>Pressure volume loop analysis unsing conductance catheter measurements during right heart catheterization.</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tricuspid valve repair or replacement</intervention_name>
    <description>Tricuspid valve repair or replacement using a surgical or interventionale approach according to local heart team recommendation and patients' preference.</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood serum, whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients with severe functional tricuspid regurgitation planned for surgical or
        interventional tricuspid valve repair or replacement.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Severe functional tricuspid regurgitation.

          -  Planned surgical or interventional tricuspid valve repair or replacement.

          -  Able to cycle on a semisupine tilting exercise table.

          -  Informed consent.

        Exclusion Criteria:

          -  Coronary artery disease with significant ischemia.

          -  Unstable Angina.

          -  Myocardial infarction &lt;4 month prior to inclusion.

          -  Concomitant valvular heart disease (aortic, mitral or pulmonary valve) &gt;
             mild-moderate.

          -  Constrictive pericarditis.

          -  Malignant disease with a life expectancy &lt; 12 months.

          -  Pregnancy.

          -  Insufficient image quality on echocardiography.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philipp Lurz, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Leipzig</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Philipp Lurz, MD, PhD</last_name>
    <phone>+49341865252022</phone>
    <email>philipp.lurz@medizin.uni-leipzig.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maximilian von Roeder, MD</last_name>
    <phone>+49341865252517</phone>
    <email>maximilian.vonroeder@medizin.uni-leipzig.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Heart Center Leipzig at Leipzig University</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philipp Lurz, MD, PhD</last_name>
      <phone>+49341865252022</phone>
      <email>Philipp.Lurz@medizin.uni-leipzig.de</email>
    </contact>
    <contact_backup>
      <last_name>Maximilian von Roeder, MD</last_name>
      <phone>+49341865252517</phone>
      <email>maximilian.vonroeder@medizin.uni-leipzig.de</email>
    </contact_backup>
    <investigator>
      <last_name>Philipp Lurz, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maximilian von Roeder, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 24, 2019</study_first_submitted>
  <study_first_submitted_qc>October 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 28, 2019</study_first_posted>
  <last_update_submitted>October 25, 2019</last_update_submitted>
  <last_update_submitted_qc>October 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Leipzig</investigator_affiliation>
    <investigator_full_name>Philipp Lurz</investigator_full_name>
    <investigator_title>Prof. Philipp Lurz, M.D., Ph.D.</investigator_title>
  </responsible_party>
  <keyword>tricuspid regurgitation</keyword>
  <keyword>heart failure</keyword>
  <keyword>right heart</keyword>
  <keyword>stress echocardiography</keyword>
  <keyword>tricuspid repair</keyword>
  <keyword>tricuspid replacement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tricuspid Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

